They induced experimental anti-myeloperoxidase (MPO) glomerulonephritis and triggered it by injecting an anti-glomerular basement membrane antibody to activate the recruited neutrophils, degranulate them in the site and to deposit MPO in the glomerular capillary bed and recruit MPO-specific CD4 + cells. Here, MPO is linked to glomerulonephritis.